Klein Matthew B.'s Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed May 15, 2026
- Accession no.
- 0001808968-26-000015
- Filed
- May 15, 2026
- Trade date
- May 13-14, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions. Open-market sales total $917.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Matthew B.CIK 0001808968 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | AGrant or awardAcquired | +12,500 | $0.00 | $0 | 406,570 | Direct | |
| May 14, 2026 | Common Stock | SSaleDisposed | −679 | $73.06 | −$49,607.74 | 405,891 | Direct | |
| May 14, 2026 | Common Stock | SSaleDisposed | −7,221 | $73.08 | −$527,710.68 | 398,670 | Direct | |
| May 14, 2026 | Common Stock | SSaleDisposed | −2,100 | $73.08 | −$153,468 | 396,570 | Direct | |
| May 14, 2026 | Common Stock | SSaleDisposed | −2,572 | $72.46 | −$186,367.12 | 393,998 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.